|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.75 AUD | -3.37% |
|
-1.01% | -3.92% |
| Apr. 24 | Germany's Evotec Appoints Permanent CEO | MT |
| Apr. 18 | Evotec, Variant Bio Team Up to Develop Treatment for Fibrosis | MT |
EVT Limited reported earnings results for the half year ended December 31, 2023. For the half year, the company reported net income was AUD 27.1 million compared to AUD 96.74 million a year ago. Basic earnings per share from continuing operations was AUD 0.167 compared to AUD 0.6 a year ago.
Diluted earnings per share from continuing operations was AUD 0.167 compared to AUD 0.593 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -3.92% | 1.24B | |
| +17.97% | 4.62B | |
| +25.27% | 2.16B | |
| -.--% | 1.88B | |
| -15.44% | 1.65B | |
| -10.07% | 1.4B | |
| -10.51% | 1.14B | |
| -20.74% | 1.1B | |
| -44.28% | 942M | |
| -.--% | 818M |
EVT LIMITED 
